LifeStance Health Group

Lifestance Health Group, Inc. provides outpatient mental health services. It offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy. The firm operates outpatient mental health platform as well as offers patients care virtually through its online delivery platform or in-person at its centers in 32 states. The company was founded by Michael K. Lester, Gwen H. Booth and Danish J. Qureshi in 2017 and is headquartered in Scottsdale, AZ.

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

LifeStance Health Group reports strong Q4 performance and outlines growth strategies for 2023

LifeStance Health Group's Q4 2022 performance reflects financial stability and operational strength, meeting expectations.
The company's strategic focus on long-term profitability, clinician growth, and value-based care positions it for future success.
Challenges include consolidation efforts, payer contracting complexities, and transitioning to an integrated care model.
Opportunities for growth lie in collaboration with physical care providers, value-based care models, and data-driven approaches.

LifeStance Health Group exceeds Q1 expectations, eyes sustainable growth

LifeStance Health Group's Q1 2023 performance showcased strong financial results and operational advancements, driven by clinician growth and strategic initiatives.
While facing challenges such as clinician recruitment and margin progression, the company's focus on retention and value-based care initiatives bodes well for future growth.
With opportunities in clinician expansion, operational enhancements, and market adaptation, LifeStance Health Group is poised to capitalize on emerging trends and drive sustainable success.

LifeStance Health Group excels in Q2, eyes growth opportunities

LifeStance Health Group's Q2 2023 earnings call highlighted strong financial performance, operational improvements, and a strategic focus on enhancing patient care and value-based care arrangements. The company is navigating challenges in streamlining operations and adapting to regulatory changes while capitalizing on opportunities to drive growth and operational efficiencies.

LifeStance Health Group exceeds Q3 expectations, focuses on growth

LifeStance Health Group's Q3 2023 performance reflects strong revenue growth, operational improvements, and a focus on patient and clinician satisfaction.
While facing challenges such as negative free cash flow and ongoing legal actions, the company is poised for growth through revenue guidance increases and strategic investments.
Opportunities for revenue growth, clinician expansion, and enhanced patient experiences align with the company's commitment to quality care and financial performance.
CEO Ken Burdick's emphasis on exceeding expectations, raising guidance, and navigating legal challenges underscores the company's resilience and strategic direction.

LifeStance Health Group beats 2023 metrics, focuses on growth optimization

LifeStance Health Group's strong financial performance in 2023 reflects a focus on profitability, clinician growth, and patient experience, with plans for continued optimization.
Strategic investments in technology and operational processes position the company for future success, while challenges in moderating growth and improving funnel efficiency require attention.
Opportunities lie in enhancing patient acquisition and retention, clinician productivity, and operational efficiency, leveraging the company's early growth stage for scalability.
Management's commitment to a purpose-driven culture and operational excellence, supported by a dedicated team, underpins LifeStance Health Group's path to sustained success.

LifeStance Health Group excels in Q1 2024, eyes growth opportunities

LifeStance Health Group's Q1 2024 Earnings Call showcased robust financial performance, strategic resilience, and a focus on growth. While facing leadership transitions and short-term challenges, the company is poised for positive cash flow and continued improvements in revenue and margins.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

SCOTTSDALE, Ariz. , Dec. 22, 2022 /PRNewswire/ -- LifeStance Health (NASDAQ: LFST), one of the nation's largest providers of outpatient mental health care, today announced it has been Certified™ by Great Place to Work® for the second year in a row.

LifeStance Health Earns 2022 Great Place to Work Certification™

SCOTTSDALE, Ariz., Dec. 21, 2022 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (NASDAQ: LFST), one of the nation's largest providers of outpatient mental health care, today announced that management will present at the upcoming 41st Annual J.P. Morgan Healthcare Conference, which will be hosted in San Francisco, CA.

LifeStance to Present at the 41st Annual J.P. Morgan Healthcare Conference

LifeStance to Present in the 41st Annual J.P. Morgan Healthcare Conference

LifeStance Health Group, Inc. (NASDAQ:LFST ) Q3 2022 Earnings Conference Call November 8, 2022 4:30 PM ET Company Participants Monica Prokocki - Vice President of Investor Relations Ken Burdick - Chairman & Chief Executive Officer Mike Bruff - Chief Financial Officer Danish Qureshi - President & Chief Operating Officer Conference Call Participants Craig Hettenbach - Morgan Stanley Lisa Gill - JP Morgan Brian Tanquilut - Jefferies Jack Senft - William Blair Jamie Perse - Goldman Sachs Operator Ladies and gentlemen, thank you for standing by and welcome to the LifeStance Health Third Quarter 2022 Earnings Call. I would now like to turn the call over to Monica Prokocki, VP of Investor Relations.

LifeStance Health Group, Inc. (LFST) Q3 2022 Earnings Call Transcript

LifeStance Health (LFST) delivered earnings and revenue surprises of 26.67% and 0.97%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

LifeStance Health Group (LFST) Reports Q3 Loss, Lags Revenue Estimates

SCOTTSDALE, Ariz., Nov. 08, 2022 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (NASDAQ: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial results for the quarter ended September 30, 2022.

LifeStance Reports Third Quarter 2022 Results

SCOTTSDALE, Ariz. , Nov. 3, 2022 /PRNewswire/ --  LifeStance Health (NASDAQ: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced that effective November 10, 2022, J.

LifeStance Health Appoints J. Michael Bruff as New Business Transformation Officer; David Bourdon as Chief Financial Officer

SCOTTSDALE, Ariz., Oct. 18, 2022 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (NASDAQ: LFST), one of the nation's largest providers of outpatient mental health care, will issue its third quarter earnings release after the market closes on Tuesday, November 8, 2022.

LifeStance to Host Third Quarter 2022 Earnings Conference Call on November 8, 2022

NEW YORK , Oct. 12, 2022 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of LifeStance Health Group, Inc.. Shareholders who purchased shares of LFST during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment.

SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of LifeStance Health Group, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of October 11, 2022 - (NASDAQ: LFST)

Los Angeles, California--(Newsfile Corp. - October 11, 2022) - The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against LifeStance Health Group, Inc. ("LifeStance" or "the Company") (NASDAQ: LFST) for violations of the federal securities laws.

DEADLINE TODAY: The Schall Law Firm Encourages Investors in LifeStance Health Group, Inc. with Losses of $100,000 to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / October 10, 2022 / The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against LifeStance Health Group, Inc. ("LifeStance" or "the Company") (NASDAQ:LFST) for violations of the federal securities laws. Investors who purchased the Company's shares pursuant and/or traceable to the Company's initial public offering conducted on June 10, 2021 (the "IPO"), are encouraged to contact the firm before October 11, 2022.

FINAL DEADLINE TOMORROW: The Schall Law Firm Encourages Investors in LifeStance Health Group, Inc. With Losses to Contact the Firm

LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz reminds investors of the upcoming October 11, 2022 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who acquired LifeStance Health Group, Inc. (“LifeStance” or the “Company”) (NASDAQ: LFST) common stock pursuant and/or traceable to the Registration Statement and Prospectus issued in connection with LifeStance's June 10, 2021 initial public stock offering (the “IPO”). If you are a shareholder

The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against LifeStance Health Group, Inc. (LFST)

Los Angeles, California--(Newsfile Corp. - October 10, 2022) -  The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against LifeStance Health Group, Inc. ("LifeStance" or "the Company") (NASDAQ: LFST) for violations of the federal securities laws.

DEADLINE TOMORROW: The Schall Law Firm Encourages Investors in LifeStance Health Group, Inc. with Losses of $100,000 to Contact the Firm

New York, New York--(Newsfile Corp. - October 8, 2022) - Pomerantz LLP is investigating claims on behalf of investors of LifeStance Health Group, Inc. ("LifeStance" or the "Company") (NASDAQ: LFST). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980.The investigation concerns whether LifeStance and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of LifeStance Health Group, Inc. - LFST

New York, New York--(Newsfile Corp. - October 7, 2022) - Levi & Korsinsky, LLP notifies investors in LifeStance Health Group, Inc. ("LifeStance" or the "Company") (NASDAQ: LFST) of a class action securities lawsuit.The lawsuit on behalf of LifeStance investors has been commenced in the the United States District Court for the Southern District of New York.

LifeStance Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before October 11, 2022 to Discuss Your Rights - LFST

Los Angeles, California--(Newsfile Corp. - October 7, 2022) - The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against LifeStance Health Group, Inc. ("LifeStance" or "the Company") (NASDAQ: LFST) for violations of the federal securities laws.

SHAREHOLDER ACTION NOTICE: The Schall Law Firm Encourages Investors in LifeStance Health Group, Inc. with Losses of $100,000 to Contact the Firm

NEW YORK , Oct. 7, 2022 /PRNewswire/ -- Jakubowitz Law announces that a securities fraud class action lawsuit has commenced on behalf of shareholders of LifeStance Health Group, Inc. (NASDAQ: LFST). To receive updates on the lawsuit, fill out the form: https://claimyourloss.com/securities/lifestance-health-group-inc-loss-submission-form/?id=32437&from=4 This lawsuit is on behalf of all purchasers of LifeStance common stock pursuant and/or traceable to the documents issued in connection with LifeStance's June 10, 2021 initial public stock offering.

LFST SHAREHOLDER ALERT: Jakubowitz Law Reminds LifeStance Shareholders of a Lead Plaintiff Deadline of October 11, 2022

LOS ANGELES, CA / ACCESSWIRE / October 6, 2022 / The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against LifeStance Health Group, Inc. ("LifeStance" or "the Company") (NASDAQ:LFST) for violations of the federal securities laws. Investors who purchased the Company's shares pursuant and/or traceable to the Company's initial public offering conducted on June 10, 2021 (the "IPO"), are encouraged to contact the firm before October 11, 2022.

FINAL DEADLINE IMMINENT: The Schall Law Firm Encourages Investors in LifeStance Health Group, Inc. With Losses to Contact the Firm

New York, New York--(Newsfile Corp. - October 6, 2022) - Levi & Korsinsky, LLP notifies investors in LifeStance Health Group, Inc. ("LifeStance" or the "Company") (NASDAQ: LFST) of a class action securities lawsuit.The lawsuit on behalf of LifeStance investors has been commenced in the the United States District Court for the Southern District of New York.

LifeStance Class Action: Levi & Korsinsky Reminds LifeStance Health Group, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 11, 2022 - LFST

Los Angeles, California--(Newsfile Corp. - October 6, 2022) - The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against LifeStance Health Group, Inc. ("LifeStance" or "the Company") (NASDAQ: LFST) for violations of the federal securities laws.

SHAREHOLDER ACTION REMINDER: The Schall Law Firm Encourages Investors in LifeStance Health Group, Inc. with Losses of $100,000 to Contact the Firm

NEW YORK , Oct. 6, 2022 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in LifeStance Health Group, Inc. ("LifeStance" or the "Company") (NASDAQ: LFST) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of LifeStance investors who were adversely affected by alleged securities fraud.

LFST LAWSUIT ALERT: Levi & Korsinsky Notifies LifeStance Health Group, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline

Did you lose money on investments in LifeStance Health Group? If so, please visit LifeStance Health Group, Inc. Shareholder Class Action Lawsuit or contact Peter Allocco at (212) 951-2030 or pallocco@bernlieb.com to discuss your rights.

LIFESTANCE HEALTH GROUP, INC. (LFST) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against LifeStance Health Group, Inc. (LFST)

CEDARHURST, N.Y. , Oct. 5, 2022 /PRNewswire/ -- The securities litigation law firm of Kuznicki Law PLLC issues this alert to shareholders of LifeStance Health Group, Inc. (NasdaqGS: LFST), if they purchased the Company's Class A common stock pursuant and/or traceable to the Company's June 2021 initial public offering (the "IPO").

FILING DEADLINE--Kuznicki Law PLLC Announces Class Action on Behalf of Shareholders of LifeStance Health Group, Inc. - LFST

LOS ANGELES , Oct. 5, 2022 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against LifeStance Health Group, Inc. ("LifeStance" or the "Company") (NASDAQ: LFST).

LFST Investors Have Opportunity to Lead LifeStance Health Group, Inc. Securities Fraud Lawsuit

LOS ANGELES, CA / ACCESSWIRE / October 4, 2022 / The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against LifeStance Health Group, Inc. ("LifeStance" or "the Company") (NASDAQ:LFST) for violations of the federal securities laws. Investors who purchased the Company's shares pursuant and/or traceable to the Company's initial public offering conducted on June 10, 2021 (the "IPO"), are encouraged to contact the firm before October 11, 2022.

News for LifeStance Health Group Stock (LFST)